PCN DES Outline Specifications consultation and costings update
Thanks for your input and support with the recent PCN DES Specifications consultation. The numbers speak for themselves. The overwhelming mood is one of frustration with loudly voiced opposition and anger to the NHSE&I proposals.
We received 725 responses in just one week with 88% feeding back that NHSE&I’s published draft Specifications would decrease PCN stability, and 94% saying that they would decrease practice financial stability. Grass roots GP practices sent a clear message to NHSE&I that however many opportunities the system believes PCNs may offer, it is core general practice that is key to delivering them and it is the core of general practice that must also be sustained.
Armed with all the numbers and analysis garnered from the more detailed feedback in the free text boxes, Londonwide GPs and practices' feelings were fully represented at last week’s GPC meeting where the NHSE&I proposals were overwhelmingly rejected and an emergency motion to hold a Special Conference of LMC Representatives was overwhelmingly supported. This will take place once further negotiations are completed.
The point has been made loud and clear that the Service Specifications will need to be delivered by the whole practice team and will have a significant impact on practice viability over the coming year. Headline figures from the responses we received are below.
We are also grateful to Londonwide LMCs’ Medical Director Dr Elliott Singer for his work on modelling possible delivery costs for two of the new Service Specifications. His modelling reveals that the resources required to deliver just two of the five draft PCN DES Outline Service Specifications far outstrip the resource aligned with the outlined measures. You can read his calculations here, with indicative headlines for the workings on the Structured Medications Review below.
Indicative Structured Medication Review (SMR) workload requirement/ costings per PCN
Note: at the time of writing (22/01/2020) negotiations are ongoing.
Workings indicate that a PCN covering 50,000 patients with average instances of reported incidents (based on nationally provided figures) would require the following:
- Allowing for an average time per SMR 20minutes (double consultation), which is a maximum of 12 SMRs per 4h session; A WTE pharmacist working 10 sessions per week = capacity of 400 sessions per annum = 4,800 SMRs per annum.
- Calculations indicate an average of 4,739 SMR per PCN (across: care home, polypharmacy, multiple LTCs, falls, severe frailty).
- Requirement to cover this SMR Specification = 1 WTE pharmacist
- If you add-in patients on hypertensive, antiplatelet or NSAID, but take from this figure the ones on 10+ medications this will require an additional 13,644 SMRs per annum per PCN.
- A WTE pharmacist would need to work an additional 1,137 sessions per annum to complete this add-on work.
- Requirement to cover the additional activity to SMR specification = extra 2.8 WTE pharmacists
- Additional cost for a clinical lead to oversee and support pharmacist in this work assuming 5% of patients (237-919 patients) need further review = 20-77 sessions per annum.
- Clinical lead support = 0.4-1.5 sessions per week
- Administrative support to maintain register and ensure the patient is invited and attends appointment, assuming on average take 10min per patient per annum =790– 3,063 hrs per annum.
- Administrative support = 0.4-1.6 WTE
- Cost of office disposables, equipment use, building wear/ tear, room use etc not included.
The draft specifications and contract documents currently indicate that PCNs will be reimbursed up to 70% of costs for pharmacist positions up to 3.8 roles.
PCNs are liable for the additional 30% salary costs for pharmacists conducting the SMR, and for costs associated with clinical and administrative support and office disposables.
Headline figures from the responses we recieved
Does delivering these Service Specifications increase or decrease the stability of your practice in relation to: |
Number of responses (Base: 725, no answer: 28) |
Percentage response |
Decrease or similar Financial stability |
655 |
94% |
Decrease or similar Workforce stability |
639 |
91.7% |
Decrease or similar PCN viability |
611 |
88% |
Q2.
Are the resources outlined in the Service Specifications proportionate to the activity your practice and PCN would be delivering? |
Number of responses |
Percentage response |
|
No or similar |
716 |
98.8% |
Q3.
Are there sufficient numbers of GPs within your practice and PCN to deliver the GP led activity envisioned in the Service Specifications, oversee the other roles who will be delivering activity and manage the DES? |
Number of responses |
Percentage response |
|
No or similar |
719 |
99.2% |
Q4.
Are there sufficient numbers of the other roles within your practice and PCN to deliver the non-GP led activity envisioned in the Service Specifications? Are you confident that you will be able to recruit to these posts in the time frames set out in the event more staff are required? |
Number of responses |
Percentage response |
|
No or similar |
716 |
98.8% |
For information, the Londonwide LMCs' survey (now closed) can be seen here.
Last updated : 20 Feb 2020Latest LMC workforce survey - please complete our short survey by Friday 17 December 2021 (25 Nov 2021)
We have extended the closing date of our workforce survey to 17:00 on Friday 17 December, in recognition of the substantial time pressures on practices. Please do still take 10...Help us respond to the Health and Social Care Select Committee enquiry into ‘The Future of General Practice’ (25 Nov 2021)
We will be responding to this new inquiry as on behalf of London general practice and would welcome your views. We will highlight London GP teams’ commitment to patient access,...New Integrated Care Board CEOs (23 Nov 2021)
The five chief executive roles for London’s Integrated Care Boards (ICBs) have been appointed. They are: North West London: Rob Hurd, current North Central London ICS Joint Executive lead. North...Update: GP earnings declarations delayed until at least next Spring (22 Nov 2021)
Last week we were informed by the General Practitioners Committee England (GPC England) of the BMA that they had further discussions with the Department of Health and Social Care (DHSC)...Londonwide LMCs' Buying Group - flu vaccine offer (03 Nov 2021)
The Londonwide LMCs’ Buying Group offers discounted rates on flu vaccines via our buying group supplier MidMeds. Member practices should call Mylan (0800 358 7468), or Seqirus (08457 451 500),...Covid-19 guidance update – October 2021 (20 Oct 2021)
This page collates new guidance and existing guidance that has been updated since our last newsletter on 22 September. Covid-19 vaccination programme Covid-19 vaccination deployment next steps for...Tips of the Month October 2021 (20 Oct 2021)
We provide monthly tips based on common queries which come through to us from London GPs and practice teams. These are shared via social media and collated for...Guidance
We provide expert guidance for practices in our guidance section, as well as an archive of other materials you may find useful.
GP Support
Contact our GP Support team if you need help or advice.
The team provide professional and pastoral support to GPs and practice teams on a broad range of issues.